238 related articles for article (PubMed ID: 25610755)
1. Pathogen-inspired drug delivery to the central nervous system.
McCall RL; Cacaccio J; Wrabel E; Schwartz ME; Coleman TP; Sirianni RW
Tissue Barriers; 2014; 2(4):e944449. PubMed ID: 25610755
[TBL] [Abstract][Full Text] [Related]
2. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.
Liu Y; Li J; Shao K; Huang R; Ye L; Lou J; Jiang C
Biomaterials; 2010 Jul; 31(19):5246-57. PubMed ID: 20382424
[TBL] [Abstract][Full Text] [Related]
3. Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery.
Zhan C; Yan Z; Xie C; Lu W
Mol Pharm; 2010 Dec; 7(6):1940-7. PubMed ID: 20964364
[TBL] [Abstract][Full Text] [Related]
4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
5. A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery.
Liu Y; He X; Kuang Y; An S; Wang C; Guo Y; Ma H; Lou J; Jiang C
Mol Pharm; 2014 Oct; 11(10):3330-41. PubMed ID: 24964270
[TBL] [Abstract][Full Text] [Related]
6. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
7. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
8. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
Andrieux K; Couvreur P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between NMDA and GABA(A) receptors in cultured neurons of the rat inferior colliculus.
Cong D; Tang Z; Li L; Huang Y; Wang J; Chen L
Sci China Life Sci; 2011 Jun; 54(6):560-6. PubMed ID: 21706417
[TBL] [Abstract][Full Text] [Related]
10. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
11. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
12. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
13. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
14. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
15. Why study transport of peptides and proteins at the neurovascular interface.
Pan W; Kastin AJ
Brain Res Brain Res Rev; 2004 Aug; 46(1):32-43. PubMed ID: 15297153
[TBL] [Abstract][Full Text] [Related]
16. 2-Guanidine-4-methylquinazoline acts as a novel competitive antagonist of A type γ-aminobutyric acid receptors.
Xiao X; Zhu MX; Xu TL
Neuropharmacology; 2013 Dec; 75():126-37. PubMed ID: 23916476
[TBL] [Abstract][Full Text] [Related]
17. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase.
Danjo S; Ishihara Y; Watanabe M; Nakamura Y; Itoh K
Brain Res; 2013 Sep; 1530():44-53. PubMed ID: 23831997
[TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of stem cells as therapy for central nervous system disease.
Li YH; Feng L; Zhang GX; Ma CG
Exp Mol Pathol; 2015 Apr; 98(2):145-51. PubMed ID: 25645932
[TBL] [Abstract][Full Text] [Related]
19. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
20. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
